1. Ghimire S, Weber D, Mavin E, Wang XN, Dickinson AM, Holler E. Pathophysiology of GvHD and Other HSCT-Related Major Complications. Front Immunol 2017; 8: 79.
2. Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA, et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 2011; 4: 1413-20.
4. H. Ahlman, O. Nilsson. The gut as the largest endocrine organ in the body. Ann Oncology 2001;12 (suppl 2): S63-8.
6. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. Ghrelin, a novel growth hormone-releasing acylatedpeptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-4256.
7. Gualillo O, Caminos J., Blanco M, Garcia-Caballero T, Kojima M, Kangawa K, et al. Ghrelin, a novel placental-derived hormone. Endocrinology 2001; 142: 788-794.
8. Burckhardt B, Delco F, Ensinck JW, Meier R., Bauerfeind P, Aufderhaar J, et al. Cholecystokinin is a physiological regulator of gastric acid secretion in man. Eur J Clin Invest 1994; 24: 370-376.
9. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbalder contraction. J Clin Invest 1985; 75: 1144-1152.
10. Fehmann HC, Goke R, Goke B. Cell and molecular biology of the incretin hormones
glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocrine
Reviews 1995; 15: 390-407.
11. George SK, Uttenthal LO, Ghiglione M, Bloom SR. Molecular forms of glucagon like peptides in man. FEBS Lett 1985; 192: 275-278.
12. Iglesias P, Selgas R, Romero S, Dı´ez J. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. Eur J Endocrinol 2012;167: 301-309.
13. WHO Handbook 1979: 15-22.
14. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002; 5: 124-129.
15. Douglas BR, Woutersen RA, Jansen JB, de Jong AJ, Lamers CB. The influence of different nutriens on plasma cholecystokinin levels in rat. Experientia 1988; 44: 21-23.
16. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J ClinEndocrinolMetab 2001; 86: 5992-5995.
17. WHO Anthro (version 3.2.2, January 2011) and macros [https://www.who.int/childgrowth/software/en/]
18. Gołąb S, Chrzanowska M. Child of Krakow region 2000. Biological development of children and adolescents in Krakow city. Poziom rozwoju biologicznego dzieci i młodzieży miasta Krakowa. Studia i Monografie AWF w Krakowie 2000: 19
19. Palczewska I, Niedźwiecka Z. Indices of somatic development of Warsaw children and adolescents. (Wskaźniki rozwoju somatycznego dzieci i młodzieży warszawskiej). Med. Wieku Rozwoj 2001: 2 (supl. 1).
20. Kushner RF, Schoeller DA. Estimation of total body water by bioelectrical impedance analysis. Am J ClinNutr 1986: 44: 417-424
21. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis. Cancer 2004; 100: 2026–2046
22. Gosselin KB, Feldman HA, Sonis AL, Bechard LJ, Kellog EM, et al. Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation (HCT) in children. J Pediatr Gastroenterol Nutr 2014; 58: 709–714.
23. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 2008; 27:328–339.
24. Rabier D, Kamoun P. Metabolism of citrulline in man. Amino Acids 1995; 9: 299-316.
25. Markan KR, Naber MC, Ameka MK, Anderegg MD, Mangelsdorf DJ, Kliewer SA, et al. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 63; 12: 4057–63.
27. Karaca F, Afsar CU, Gunaldi M, Erkurt E, Ercolak V, Sertdemir Y, et al. Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. Int J Clin Exp Med 2015; 8: 876–882.
28. Wang Z, Yang WL, Jacob A, Aziz M, Wang P. Human Ghrelin Mitigates Intestinal Injury and Mortality after Whole Body Irradiation in Rats. PLoS One 2015; 10: e0118213.
29. Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, et al. Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin. Diabetes 2012; 61: 897-907.
30. Han Y, Su C, Yu D, Zhou S, Song X, Liu S, et al. Cholecystokinin attenuates radiation-induced lung cancer cell apoptosis by modulating p53 gene transcription. Am J Transl Res 2017; 15: 638-646.
- Yang C, Lu W, Lin T, You P, Ye M, Huang Y, et al. Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress. BMC Gastroenterol 2013; 17: 67.